ConductScience.org, home

Paper190995

A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).

Nazerian K and 5 others. Avian Dis, 1977. Cited by 119 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV). Papers, record 190995. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/190995

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV).
PubMed
Journal
Avian Dis
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
2.85
iCite
Revised in PubMed
2003-11-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nazerian KK
2Stephens EAE A
3Sharma JMJ M
4Lee LFL F
5Gailitis MM
6Witter RLR L

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell LineMajor topic
ChickensMajor topic
Marek DiseaseMajor topic
T-LymphocytesMajor topic
Animals
Antigens, Neoplasm
Antigens, Viral
DNA, Viral
Herpesvirus 2, Gallid
Histocompatibility Antigens
Neoplasm Transplantation
Nucleic Acid Hybridization
Spleen
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
36146821The Importance of the Bursa of Fabricius, B Cells and T Cells for the Pathogenesis of Marek's Disease: A Review.Viruses2022https://conductscience.org/library/papers/36146821PubMed
26612074Marek's disease virus undergoes complete morphogenesis after reactivation in a T-lymphoblastoid cell line transformed by recombinant fluorescent marker virus.J Gen Virol2016https://conductscience.org/library/papers/26612074PubMed
22090140Epigenetic regulation of the latency-associated region of Marek's disease virus in tumor-derived T-cell lines and primary lymphoma.J Virol2012https://conductscience.org/library/papers/22090140PubMed
21573129Clonal structure of rapid-onset MDV-driven CD4+ lymphomas and responding CD8+ T cells.PLoS Pathog2011https://conductscience.org/library/papers/21573129PubMed
21302075Histocompatibility typing by cellular radioimmunoassay.Immunogenetics1978https://conductscience.org/library/papers/21302075PubMed
17016434The activation of TC10, a Rho small GTPase, contributes to v-Rel-mediated transformation.Oncogene2007https://conductscience.org/library/papers/17016434PubMed
16352553Mechanism of telomerase activation by v-Rel and its contribution to transformation.J Virol2006https://conductscience.org/library/papers/16352553PubMed
12072527Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.J Virol2002https://conductscience.org/library/papers/12072527PubMed
11997525A novel interferon regulatory factor (IRF), IRF-10, has a unique role in immune defense and is induced by the v-Rel oncoprotein.Mol Cell Biol2002https://conductscience.org/library/papers/11997525PubMed
11533227Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts.Mol Cell Biol2001https://conductscience.org/library/papers/11533227PubMed
9420237Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis.J Virol1998https://conductscience.org/library/papers/9420237PubMed
7710361Identification and characterization of a cDNA clone derived from the Marek's disease tumour cell line RPL1 encoding a homologue of alpha-transinducing factor (VP16) of HSV-1.Arch Virol1995https://conductscience.org/library/papers/7710361PubMed
6874076Development and characterization of monoclonal antibodies to Marek's disease tumor-associated surface antigen.Infect Immun1983https://conductscience.org/library/papers/6874076PubMed
6287971Circular forms of viral DNA in Marek's disease virus-transformed lymphoblastoid cells.Arch Virol1982https://conductscience.org/library/papers/6287971PubMed
6273319Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines.Infect Immun1981https://conductscience.org/library/papers/6273319PubMed
6251256Replication of the resident Marek's Disease virus genome in synchronized nonproducer MKT-1 cells.J Virol1980https://conductscience.org/library/papers/6251256PubMed
1315048Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1315048PubMed
227789In vitro replication of infectious bursal disease virus in established lymphoid cell lines and chicken B lymphocytes.Infect Immun1979https://conductscience.org/library/papers/227789PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/190995

GET https://conductscience.org/api/papers/v1/190995/authors